Iron Deficiency Treatment Guidelines
Clinical Rationale for Treatment
- Iron deficiency causes symptoms and impairs quality of life even when fully developed anemia is not yet present, and treatment is strongly justified when symptoms are present, according to the Journal of Crohn's and Colitis 1, 2, 3, 4, 5
- The decision to supplement iron in patients with ferropenia but without anemia depends on the clinical scenario and patient symptoms 4, 5
Diagnostic Thresholds
- Serum ferritin <30 μg/L indicates iron deficiency in patients without clinical, endoscopic, or biochemical evidence of active disease, as stated by Clinical Nutrition 6, 7
- Serum ferritin up to 100 μg/L may still be consistent with iron deficiency in the presence of inflammation, according to Clinical Nutrition 6, 7
Evidence-Based Treatment Approach
- Treatment is recommended for symptomatic patients with fatigue, cognitive impairment, or other iron deficiency symptoms, and for IBD patients with ferritin <100 μg/L, as recommended by the Journal of Crohn's and Colitis 1, 2, 3, 4, 5
- Intravenous iron therapy is preferred in IBD patients with ferritin <100 μg/L, and is indicated for oral iron intolerance, malabsorption, and chronic inflammatory conditions, as stated by Clinical Nutrition and the Journal of Crohn's and Colitis 1, 2, 3, 6, 7
- Ferric carboxymaltose prevents anemia recurrence better than placebo (27% vs 40%, HR 0.62), according to the Journal of Crohn's and Colitis 1, 2, 3
Special Populations
- The European Crohn's and Colitis Organization (ECCO) guidelines specifically recommend proactive iron replacement when ferritin drops below 100 μg/L, even without anemia, to reduce anemia recurrence, decrease IBD flares, and improve cost-effectiveness, as stated by the Journal of Crohn's and Colitis and Clinical Nutrition 1, 2, 3, 6
- Iron deficiency (even without anemia) in heart failure patients should be treated as it improves functional capacity, quality of life, and reduces hospitalizations, according to the American Journal of Hematology 8